Massachusetts-based InVivo Therapeutics looks to raise $12 million in a direct offering as it enrolls the 2nd patient in a feasibility trial for its neuro-spinal scaffold.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1yvpELR
Cap comentari:
Publica un comentari a l'entrada